cgmp phosphodiesterase
Recently Published Documents


TOTAL DOCUMENTS

279
(FIVE YEARS 7)

H-INDEX

45
(FIVE YEARS 1)

2020 ◽  
Vol 432 (21) ◽  
pp. 5765-5783
Author(s):  
Richa Gupta ◽  
Yong Liu ◽  
Huanchen Wang ◽  
Christopher T. Nordyke ◽  
Ryan Z. Puterbaugh ◽  
...  

2020 ◽  
Vol 77 (5) ◽  
pp. 963-963
Author(s):  
Alexandr V. Bazhin ◽  
Vojtech Tambor ◽  
Boyan Dikov ◽  
Pavel P. Philippov ◽  
Dirk Schadendorf ◽  
...  

2019 ◽  
Vol 29 (15) ◽  
pp. 2580-2585.e4 ◽  
Author(s):  
Jean-Charles Isner ◽  
Vlad-Aris Olteanu ◽  
Alexander J. Hetherington ◽  
Aude Coupel-Ledru ◽  
Peng Sun ◽  
...  

Cancers ◽  
2019 ◽  
Vol 11 (3) ◽  
pp. 398 ◽  
Author(s):  
Peter Dietrich ◽  
Claus Hellerbrand ◽  
Anja Bosserhoff

Emerging evidence reveals crucial roles of wild type RAS in liver cancer. The delta subunit of rod-specific photoreceptor cGMP phosphodiesterase (PDE6D) regulates the trafficking of RAS proteins to the plasma membrane and thereby contributes to RAS activation. However, the expression and specific function of PDE6D in hepatocellular carcinoma (HCC) were completely unknown. In this study, PDE6D was newly found to be markedly upregulated in HCC tissues and cell lines. Overexpression of PDE6D in HCC correlated with enhanced tumor stages, tumor grading, and ERK activation. PDE6D depletion significantly reduced proliferation, clonogenicity, and migration of HCC cells. Moreover, PDE6D was induced by TGF-β1, the mediator of stemness, epithelial-mesenchymal transition (EMT), and chemoresistance. In non-resistant cells, overexpression of PDE6D conferred resistance to sorafenib-induced toxicity. Further, PDE6D was overexpressed in sorafenib resistance, and inhibition of PDE6D reduced proliferation and migration in sorafenib-resistant HCC cells. Together, PDE6D was found to be overexpressed in liver cancer and correlated with tumor stages, grading, and ERK activation. Moreover, PDE6D contributed to migration, proliferation, and sorafenib resistance in HCC cells, therefore representing a potential novel therapeutic target.


2017 ◽  
Vol 163 (3) ◽  
pp. 321-325
Author(s):  
L. V. Tat’yanenko ◽  
E. A. Khakina ◽  
A. V. Zhilenkov ◽  
P. A. Troshin ◽  
O. V. Dobrokhotova ◽  
...  

2017 ◽  
Vol 2017 ◽  
pp. 1-7 ◽  
Author(s):  
Gursev S. Dhaunsi ◽  
Mariam Yousif ◽  
Batoul Makki ◽  
Saghir Akhtar ◽  
Ibrahim F. Benter

Molecular mechanisms of the beneficial effects of angiotensin-(1-7), Ang-(1-7), in diabetes-related complications, including erectile dysfunction, remain unclear. We examined the effect of diabetes and/or Ang-(1-7) treatment on vascular reactivity and cyclic guanosine monophosphate (cGMP) phosphodiesterase (PDE) in corpus cavernosum. Male Wistar rats were grouped as (1) control, (2) diabetic (streptozotocin, STZ, treated), (3) control + Ang-(1-7), and (4) diabetic + Ang-(1-7). Following 3 weeks of Ang-(1-7) treatment subsequent to induction of diabetes, rats were sacrificed. Penile cavernosal tissue was isolated to measure vascular reactivity, PDE gene expression and activity, and levels of p38MAP kinase, nitrites, and cGMP. Carbachol-induced vasorelaxant response after preincubation of corpus cavernosum with PE was significantly attenuated in diabetic rats, and Ang-(1-7) markedly corrected the diabetes-induced impairment. Gene expression and activity of PDE and p38MAP kinase were significantly increased in cavernosal tissue of diabetic rats, and Ang-(1-7) markedly attenuated STZ-induced effects. Ang-(1-7) significantly increased the levels of nitrite and cGMP in cavernosal tissue of control and diabetic rats. Cavernosal tissue of diabetic rats had significantly reduced cGMP levels and Ang-(1-7) markedly prevented the STZ-induced cGMP depletion. This study demonstrates that attenuation of diabetes-induced PDE activity might be one of the key mechanisms in the beneficial effects of Ang-(1-7).


Sign in / Sign up

Export Citation Format

Share Document